Cargando…
Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly(®) Device for Migraine Prevention: A Review of the Available Data
So far, among the different non-invasive neurostimulation methods, only transcutaneous supraorbital nerve stimulation (t-SNS) with the Cefaly(®) (Cefaly Technology sprl, Herstal, Belgium) device has randomized controlled trial-based evidence for safety and efficacy and obtained American Food and Dru...
Autores principales: | Riederer, Franz, Penning, Sophie, Schoenen, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676766/ https://www.ncbi.nlm.nih.gov/pubmed/26467451 http://dx.doi.org/10.1007/s40122-015-0039-5 |
Ejemplares similares
-
Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device (PREMICE): a multi-centre, randomized, sham-controlled trial
por: Schoenen, J, et al.
Publicado: (2013) -
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
por: Magis, Delphine, et al.
Publicado: (2013) -
A survey on migraine attack treatment with the CEFALY(®) device in regular users
por: Penning, Sophie, et al.
Publicado: (2017) -
The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients
por: Danno, Daisuke, et al.
Publicado: (2019) -
Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects
por: Piquet, Maxime, et al.
Publicado: (2011)